Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $581 | $7 | $8 | $21 |
| - Cash | $83 | $6 | $7 | $12 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $498 | $1 | $1 | $10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | $0 | -$7 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$3 | -$7 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.28 | -0.65 | -1.98 | -6.15 |
| % Growth | -96.9% | 67.2% | 67.8% | – |
| Operating Cash Flow | -$6 | -$2 | -$7 | -$14 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$2 | -$7 | -$14 |